Skip to main content

A Phase 1/2 Study of Bleximenib in Participants With Acute Leukemia

Submitted by lucas on Thu, 07/17/2025 - 17:34
  • Read more about A Phase 1/2 Study of Bleximenib in Participants With Acute Leukemia

Testing What Happens When an Immunotherapy Drug (Pembrolizumab) is Given by Itself Compared to the Usual Treatment of Chemotherapy With Radiation After Surgery for Recurrent Head and Neck Squamous Cell Carcinoma

Submitted by lucas on Thu, 07/17/2025 - 17:34
  • Read more about Testing What Happens When an Immunotherapy Drug (Pembrolizumab) is Given by Itself Compared to the Usual Treatment of Chemotherapy With Radiation After Surgery for Recurrent Head and Neck Squamous Cell Carcinoma

ATHN Transcends: A Natural History Study of Non-Neoplastic Hematologic Disorders

Submitted by lucas on Thu, 07/17/2025 - 17:33
  • Read more about ATHN Transcends: A Natural History Study of Non-Neoplastic Hematologic Disorders

A Study of Oral Nuvisertib (TP-3654) in Patients With Myelofibrosis

Submitted by lucas on Thu, 07/17/2025 - 17:33
  • Read more about A Study of Oral Nuvisertib (TP-3654) in Patients With Myelofibrosis

A Study of E7386 in Combination With Other Anticancer Drug(s) in Participants With Solid Tumor

Submitted by lucas on Thu, 07/17/2025 - 17:33
  • Read more about A Study of E7386 in Combination With Other Anticancer Drug(s) in Participants With Solid Tumor

A Study to Investigate the Immunogenicity and Safety of mRNA-1345 Vaccine Targeting Respiratory Syncytial Virus (RSV) in High-risk Adults

Submitted by Anonymous (not verified) on Wed, 05/21/2025 - 20:31
  • Read more about A Study to Investigate the Immunogenicity and Safety of mRNA-1345 Vaccine Targeting Respiratory Syncytial Virus (RSV) in High-risk Adults

A Study to Evaluate the Effectiveness of Long-acting (LA) Cabotegravir (CAB) + Rilpivirine (RPV) LA When Given to Participants With Detectable HIV-1

Submitted by Anonymous (not verified) on Wed, 05/21/2025 - 20:30
  • Read more about A Study to Evaluate the Effectiveness of Long-acting (LA) Cabotegravir (CAB) + Rilpivirine (RPV) LA When Given to Participants With Detectable HIV-1

Study to Compare an Oral Weekly Islatravir/Lenacapavir Regimen With Standard of Care in Virologically Suppressed People With HIV-1

Submitted by Anonymous (not verified) on Wed, 05/21/2025 - 20:25
  • Read more about Study to Compare an Oral Weekly Islatravir/Lenacapavir Regimen With Standard of Care in Virologically Suppressed People With HIV-1

Study to Compare an Oral Weekly Islatravir/Lenacapavir Regimen With Bictegravir/Emtricitabine/Tenofovir Alafenamide in Virologically Suppressed People With HIV-1

Submitted by Anonymous (not verified) on Wed, 05/21/2025 - 20:21
  • Read more about Study to Compare an Oral Weekly Islatravir/Lenacapavir Regimen With Bictegravir/Emtricitabine/Tenofovir Alafenamide in Virologically Suppressed People With HIV-1

Testing Longer Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients With Cancer That Has Spread to the Brain

Submitted by kassing on Wed, 10/23/2024 - 15:42
  • Read more about Testing Longer Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients With Cancer That Has Spread to the Brain

Pagination

  • First page First
  • Previous page Previous
  • …
  • Page 9
  • Page 10
  • Page 11
  • Page 12
  • Page 13
  • Page 14
  • Page 15
  • Page 16
  • Page 17
  • …
  • Next page Next
  • Last page Last
Subscribe to